Benchmark analyst Bruce Jackson upgraded Neogenomics (NASDAQ: NEO) from Hold to Buy.

For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.

Shares of Neogenomics closed at $9.02 yesterday.